1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 29 FEBRUARY 2016

CNS Drug News 29 FEBRUARY 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Breakthrough Designation Affirms Ocrelizumab Blockbuster Potential
Industry Brief - LCT Completes Private Placement Of Shares
Industry Brief - Xadago Launched In Spain To Treat Mid- To Late-Stage PD
Industry Trend Analysis - Open Innovation Tools Crucial For Parkinson's Disease Therapy Advancement
Industry Trend Analysis - Billion Dollar Revenues Beckoning For Impax
Industry Brief - ANI And Dexcel Gain Donepezil Approval
Industry Trend Analysis - US Investment Lays MTP Global Expansion Groundwork
Industry Brief - Retrophin's RE-024 Granted European ODD To Treat PKAN
Industry Brief - MultiStem Cell Therapy Phase II Stroke Study Yield Positive Results
Industry Trend Analysis - Novel Drug Delivery Techniques Could Aid MDD Development
Industry Brief - FDA Approves Impax' Mixed Amphetamines ANDA
Industry Brief - Alexza Regains Adasuve US Rights From Teva
Industry Brief - Lannett Gains Sumatriptan Nasal Spray Approval
Industry Brief - Dosing Begins In CAM2038 Phase II Study In Opioid Dependent Patients
Industry Brief - Belbuca Buccal Film Launched In US For Chronic Pain Management
Industry Brief - FDA Breakthrough Therapy Designation For Trevena's Oliceridine
Industry Brief - Adapt Pharma's Narcan Nasal Spray Now Available In US
Industry Brief - Aequus/Supernus Enter Licensing Deal For Trokendi/Oxtellar In Canada
Industry Trend Analysis - Briviact Approval Vital To Retain US Epilepsy Market Position
Industry Brief - Neurelis Finalises Funding To Advance NRL-1 NDA Filing
Industry Brief - FDA Approves Intellipharmaceutics' Levetiracetam
Industry Brief - E Keppra Granted Japanese Approval In Certain Generalised Tonic-Clonic Seizures Patients
Industry Trend Analysis - Mixed Trial Results Will Make Risk Management Key For Future Beloranib Development
Industry Brief - FDA ODD For Remedy's Cirara In Acute SAH/SCI
Industry Trend Analysis - Neuroscience IVDs Remain An Untapped Market
Industry Trend Analysis - Fresh Data Further Undermines Addyi Earnings Potential
Industry Trend Analysis - Rising Trial Risk Will Promote Novel Methods Of Drug Development
Industry Brief - Lightlake Changes Name To Opiant Pharmaceuticals

Table Of Contents

CNS Drug News 29 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

  • $ 10995
  • Industry report
  • October 2016
  • by Global Data

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.